Skip to main content

Table 4 Comparison of basic demographic and medical data between dual and triple users

From: Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt

Variables

Type of therapy

P value Sig. (2-tailed)

Dual (n = 31)

Triple (n = 31)

Gender

 • Male

12

18

.20

 • Female

19

13

Education

 • Uneducated

17

7

.02

 • Educated

14

24

Employment

 • Employed

6

11

.24

 • Unemployed

8

9

 • Housewives

17

11

Martial status

 • Single

8

9

.50

 • Married

23

22

Area of residence

 • Rural

3

12

.02

 • Urban

28

19

Treatment experience

 • Naïve

30

24

.05

 • Experience

1

7

Diagnosis

 • Non-cirrhotic

10

21

.01

 • Cirrhotic

21

10

Mean ± SD

Age

 

56.47 ± 9.32

51.65 ± 11.03

.07

Disease duration (months)

 

81.71 ± 62.86

60.48 ± 50.94

.15

PCR-T0

 

655845.81 ± 997681.03

645348.15 ± 638028.61

.96

PCR-T1 (50 cases)

 • Negative 32 (51.6%)

 • Positive 18 (29.0%)

  1. PCR-T0 Polymerase Chain Reaction time 0, PCR-T1 Polymerase Chain Reaction time 1
  2. P value significant at two tailed
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us